Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +18.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (418)

clinicaltrialsPublishedShowing 301–350 of 531 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05256641	Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma	recruiting	Phase 1 / Phase 2	24	Jonsson Comprehensive Cancer CenterOTHER	1	Mar 10, 2026	clinicaltrials
NCT07461948	Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients	recruiting	Phase 3	15	Jonsson Comprehensive Cancer CenterOTHER	1	Mar 10, 2026	clinicaltrials